Axon (AXON) Tops Q2 EPS by 49c; raises guidance

Axon (NASDAQ: AXON) reported Q2 EPS of $1.11, $0.49 better than the analyst estimate of $0.62. Revenue for the quarter came in at $374.61 million versus the consensus estimate of $350.54 million.

GUIDANCE:

Axon sees FY2023 revenue of $1.51-1.53 billion, versus the consensus of $1.46 billion. The previous guidance was for $1.44-1.46 billion.

For earnings history and earnings-related data on Axon (AXON) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance